Treat Alzheimer's disease by traditional Chinese medicine?

Molecular Simulation

Volumn 37, Issue 11, 2011, Pages 923-931

  Sun, Mao Feng ^a,b   Chang, Tung Ti ^a,b   Chen, Kuan Chung ^a   Yang, Shun Chieh ^a   Chang, Kai Wei ^a   Tsai, Tsung Ying ^a   Chen, Hsin Yi ^c   Tsai, Fuu Jen ^a,c   Lin, Jaung Geng ^a   Chen, Calvin Yu Chian ^a,b,d,e  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c ASIA UNIVERSITY   (Taiwan)

^d HARVARD MEDICAL SCHOOL   (United States)

^e Massachusetts Institute of Technology   (United States)

Author keywords

Alzheimer's disease; docking; molecular dynamics; support vector machine; traditional Chinese medicine

Indexed keywords

ALZHEIMER'S DISEASE; CALCIUM IONS; INHIBITORY EFFECT; INTERACTION FEATURES; KAINIC ACID; LIGAND-BINDING RESIDUES; METAL CATION; MOLECULAR DYNAMICS SIMULATIONS; MOLECULAR SIMULATIONS; MULTIPLE LINEAR REGRESSIONS; PHOSPHODIESTERASES; PREDICTION MODEL; PROTEIN-LIGAND INTERACTIONS; QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIP; STRUCTURE-BASED DRUG DESIGN; SUPPORT VECTOR; TARTARIC ACIDS; TRADITIONAL CHINESE MEDICINE;

AMINO ACIDS; COMPUTER SIMULATION; LIGANDS; LINEAR REGRESSION; MATHEMATICAL MODELS; MOLECULAR DYNAMICS; NEURODEGENERATIVE DISEASES; SUPPORT VECTOR MACHINES;

MEDICINE;

EID: 80052308297     PISSN: 08927022     EISSN: 10290435     Source Type: Journal    
DOI: 10.1080/08927022.2011.577074     Document Type: Article

References (44)

1. M.D. Houslay, M. Sullivan, and G.B. Bolger, The multienzyme PDE4 cyclic adenosine monophosphate-specific phosphodiesterase family: Intracellular targeting, regulation, and selective inhibition by compounds exerting anti-inflammatory and antidepressant actions, Adv. Pharmacol. 44 (1998), pp. 225-342.
2. C. Mehats, C.B. Andersen, M. Filopanti, S.L.C. Jin, and M. Conti, Cyclic nucleotide phosphodiesterases and their role in endocrine cell signaling, Trends Endocrinol. Metab. 13 (2002), pp. 29-35. (Pubitemid 36734013)
3. D. Spina, PDE4 inhibitors: Current status, Br. J. Pharmacol. 155 (2008), pp. 308-315.
4. A.B. Burgin, O.T. Magnusson, J. Singh, P. Witte, B.L. Staker, J.M. Bjornsson, M. Thorsteinsdottir, S. Hrafnsdottir, T. Hagen, A.S. Kiselyov, L.J. Stewart, and M.E. Gurney, Design of phosphodiesterase 4D (PDE4D) allosteric modulators for enhancing cognition with improved safety, Nat. Biotechnol. 28 (2010), pp. 63-70.
5. H.F. Lu, Y.J. Chie, M.S. Yang, C.S. Lee, J.J. Fu, J.S. Yang, T.W. Tan, S.H. Wu, Y.S. Ma, S.W. Ip, and J.G. Chung, Apigenin induces caspase-dependent apoptosis in human lung cancer A549 cells through Bax- and Bcl-2-triggered mitochondrial pathway, Int. J. Oncol. 36 (2010), pp. 1477-1484.
6. M.L. Lin, Y.C. Lu, J.G. Chung, Y.C. Li, S.G. Wang, S.H. Ng, C.Y. Wu, H.L. Su, and S.S. Chen, Aloe-emodin induces apoptosis of human nasopharyngeal carcinoma cells via caspase-8-mediated activation of the mitochondrial death pathway, Cancer Lett. 291 (2009), pp. 46-58.
7. C.L. Chang, L.J. Zhang, R.Y. Chen, C.C. Wu, H.C. Huang, M.C. Roy, J.P. Huang, Y.C. Wu, and Y.H. Kuo, Quiquelignan A-H, eight new lignoids from the rattan palm Calamus quiquesetinervius and their antiradical, anti-inflammatory and antiplatelet aggregation activities, Bioorg. Med. Chem. 18 (2010), pp. 518-525.
8. T.T. Chang, H.J. Huang, K.J. Lee, H.W. Yu, H.Y. Chen, F.J. Tsai, M.F. Sun, and C.Y. Chen, Key features for designing phosphodiesterase- 5 inhibitors, J. Biomol. Struct. Dyn. 28 (2010), pp. 309-321.
9. H.J. Huang, K.J. Lee, H.W. Yu, H.Y. Chen, F.J. Tsai, and C.Y. Chen, A novel strategy for designing the selective PPAR agonist by the "sum of activity" model, J. Biomol. Struct. Dyn. 28 (2010), pp. 187-200.
10. H.J. Huang, K.J. Lee, H.W. Yu, C.Y. Chen, C.H. Hsu, H.Y. Chen, and F.J. Tsai, Structure-based and ligand-based drug design for HER 2 receptor, J. Biomol. Struct. Dyn. 28 (2010), pp. 23-37.
11. C.Y. Chen and C.Y.C. Chen, Insights into designing the dualtargeted HER2/HSP90 inhibitors, J. Mol. Graph. Model. 29 (2010), pp. 21-31.
12. C.Y.C. Chen, Virtual screening and drug design for PDE-5 receptor from traditional Chinese medicine database, J. Biomol. Struct. Dyn. 27 (2010), pp. 627-640.
13. C.Y.C. Chen, Bioinformatics, chemoinformatics, and pharmainformatics analysis of HER2/HSP90 dual-targeted inhibitors, J. Taiwan Inst. Chem. Eng. 41 (2010), pp. 143-149.
14. C.Y. Chen, Weighted equation and rules - a novel concept for evaluating protein-ligand interaction, J. Biomol. Struct. Dyn. 27 (2009), pp. 271-282.
15. C.Y. Chen, Computational screening and design of traditional Chinese medicine (TCM) to block phosphodiesterase-5, J. Mol. Graph. Model. 28 (2009), pp. 261-269.
16. C.Y. Chen, Y.H. Chang, D.T. Bau, H.J. Huang, F.J. Tsai, and C.H. Tsai, Ligand-based dual target drug design for H1N1: Swine flu - a preliminary first study, J. Biomol. Struct. Dyn. 27 (2009), pp. 171-178.
17. C.Y.-C. Chen, TCM database@Taiwan: The world's largest traditional Chinese medicine database for drug screening in silico, PLoS ONE 6 (2011), p. e15939.
18. G.L. Card, L. Blasdel, B.P. England, C. Zhang, Y. Suzuki, S. Gillette, D. Fong, P.N. Ibrahim, D.R. Artis, G. Bollag, M.V. Milburn, S.H. Kim, J. Schlessinger, and K.Y.J. Zhang, A family of phosphodiesterase inhibitors discovered by cocrystallography and scaffold-based drug design, Nat. Biotechnol. 23 (2005), pp. 201-207. (Pubitemid 40255330)
19. Accelrys Software, Inc. Discovery Studio Modeling Environment, Accelrys Software, Inc., San Diego, CA, 2009.
20. B.R. Brooks, R.E. Bruccoleri, B.D. Olafson, D.J. States, S. Swaminathan, and M. Karplus, CHARMM: A program for macromolecular energy minimization and dynamics calculations, J. Comp. Chem. 4 (1983), pp. 187-217.
21. J. Koska, V.Z. Spassov, A.J. Maynard, L. Yan, N. Austin, P.K. Flook, and C.M. Venkatachalam, Fully automated molecular mechanics based induced fit protein-ligand docking method, J. Chem. Inf. Model. 48 (2008), pp. 1965-1973.
22. J. Tirado-Rives and W.L. Jorgensen, Contribution of conformer focusing to the uncertainty in predicting free energies for protein- ligand binding, J. Med. Chem. 49 (2006), pp. 5880-5884. (Pubitemid 44484934)
23. R.E. Fan, P.H. Chen, and C.J. Lin, Working set selection using second order information for training support vector machines, J. Mach. Learn. Res. 6 (2005), pp. 1889-1918.
24. A.K. Saxena and P. Prathipati, Comparison of MLR, PLS and GA-MLR in QSAR analysis, SAR QSAR Environ. Res. 14 (2003), pp. 433-445. (Pubitemid 37458088)
25. D. Rogers and A.J. Hopfinger, Application of genetic function approximation to quantitative structure-activity relationships and quantitative structure-property relationships, J. Chem. Inf. Comput. Sci. 34 (1994), p. 854.
26. R. Fletcher, Optimization, Academic Press, New York and London, 1969.
27. R. Fletcher and C.M. Reeves, Function minimization by conjugate gradients, Comput. J. 7 (1964), pp. 148-154.
28. M.L. da Silva, A.D. Goncalves, P.R. Batista, J.D. Figueroa-Villar, P.G. Pascutti, and T.C.C. Franca, Design, docking studies and molecular dynamics of new potential selective inhibitors of Plasmodium falciparum serine hydroxymethyltransferase, Mol. Simul. 36 (2010), pp. 5-14.
29. J. Xu, L.X. Wang, H. Zhang, C.H. Yi, and W.L. Xu, Accurate quantitative structure-property relationship analysis for prediction of nematic transition temperatures in thermotropic liquid crystals, Mol. Simul. 36 (2010), pp. 26-34.
30. J. Wang, M.C. Yan, D.M. Zhao, Y. Sha, F. Li, and M.S. Cheng, Pharmacophore identification of PAK4 inhibitors, Mol. Simul. 36 (2010), pp. 53-57.
31. R.W. Wang, L. Zhou, Z.L. Zuo, X. Ma, and M. Yang, 3D-QSAR studies of checkpoint kinase 1 inhibitors based on molecular docking and CoMFA, Mol. Simul. 36 (2010), pp. 87-110.
32. A. Stavrakoudis, Computational modelling and molecular dynamics simulations of a cyclic peptide mimotope of the CD52 antigen complexed with CAMPATH-1H antibody, Mol. Simul. 36 (2010), pp. 127-137.
33. R. Zhang, Z.G. Wang, B.P. Ling, Y.J. Liu, and C.B. Liu, Docking and molecular dynamics studies on the interaction of four imidazoline derivatives with potassium ion channel (Kir6.2), Mol. Simul. 36 (2010), pp. 166-174.
34. H. Dalir, T. Nisisako, Y. Yanagida, and T. Hatsuzawa, DNA force- extension curve under uniaxial stretching, Mol. Simul. 36 (2010), pp. 221-228.
35. Y. Iwai, H. Nakamura, Y. Arai, and Y. Shimoyama, Analysis of dissociation process for gas hydrates by molecular dynamics simulation, Mol. Simul. 36 (2010), pp. 246-253.
36. C.D. Yoo, S.C. Kim, and S.H. Lee, Molecular dynamics simulation study of probe diffusion in liquid n-alkanes, Mol. Simul. 35 (2009), pp. 241-247.
37. D.X. Li, G.L. Chen, B.L. Liu, and Y.S. Liu, Molecular simulation of b-cyclodextrin inclusion complex with 2-phenylethyl alcohol, Mol. Simul. 35 (2009), pp. 199-204.
38. F. Luan, H.T. Liu, Y. Gao, and X.Y. Zhang, QSPR model to predict the thermal stabilities of second-order nonlinear optical (NLO) chromophore molecules, Mol. Simul. 35 (2009), pp. 248-257.
39. J.H. Jing, G.Z. Liang, H. Mei, S.Y. Xiao, Z.N. Xia, and Z.L. Li, Quantitative structure-mobility relationship studies of dipeptides in capillary zone electrophoresis using three-dimensional holographic vector of atomic interaction field, Mol. Simul. 35 (2009), pp. 263-269.
40. A.M. Al-Mekhnaqi, M.S. Mayeed, and G.M. Newaz, Prediction of protein conformation in water and on surfaces by Monte Carlo simulations using united-atom method, Mol. Simul. 35 (2009), pp. 292-300.
41. M.L. Mihajlovic and P.M. Mitrasinovic, Applications of the ArgusLab4/AScore protocol in the structure-based binding affinity prediction of various inhibitors of group-1 and group-2 influenza virus neuraminidases (NAs), Mol. Simul. 35 (2009), pp. 311-324.
42. K. Roy and G. Ghosh, QSTR with extended topochemical atom (ETA) indices. 11. Comparative QSAR of acute NSAID cytotoxicity in rat hepatocytes using chemometric tools, Mol. Simul. 35 (2009), pp. 648-659.
43. P. Nimmanpipug, V.S. Lee, P. Wolschann, and S. Hannongbua, Litchi chinensis-derived terpenoid as anti-HIV-1 protease agent: Structural design from molecular dynamics simulations, Mol. Simul. 35 (2009), pp. 673-680.
44. P. Ghosh and M.C. Bagchi, Comparative QSAR studies of nitrofuranyl amide derivatives using theoretical structural properties, Mol. Simul. 35 (2009), pp. 1185-1200.